Endocrine Abstracts

Hypothyroidism is associated with higher risk of cardiovascular disease and increase of blood lipids. Previous evidence indicates that high dosage of levothyroxine could be cardiotoxic. There are fewer data describing mortality in subjects after treatment and stabilization of thyroid diseases and there are no data related to subjects with treated hypothyroidism. Aim of this study was to investigate correlations between the cardiovascular risk and metabolic status [Resting Ener...

Infrared Thermography (IT) is a non-invasive method and complementary to other diagnostic techniques to identify inhomogeneity of the thermal emission of the skin. We used IT (InfRec R500, Nippon Avionics Co.; 640×480 pixel, spatial resolution 0,87 mrad, sensitivity 0.03°C at 30°C, accuracy ±1°C) to assess the variations of skin temperature of the neck region: higher mean temperature, greater thyroid function. Primary outcome of this study was to compa...

Obesity and type II diabetes have been linked to several health issues, including an increased risk of bone fractures. It is well known that an increase of visceral fat affects bone health causing fragility, mechanical strength reduction and increased propensity of fractures because of impaired bone matrix microstructure and aberrant bone cells function. Adult Danio rerio (zebrafish) represents a powerful model to study fat and bone metabolism. Then, the aim of this s...

Deep Transcranical Magnetic Stimulation (dTMS) is a non-invasive modulation technique of cortical excitability that has shown to affect the mesolimbic and mesostriatal dopaminergic pathways. Consistent with these assets, dTMS is widely used as a therapeutic tool in neuro-psychiatric disorders associated with abnormal cortical excitability and dopaminergic activity, as addiction. Hence, considering the dysfuncional role of PFC and dopaminergic reward system in controlling appet...

The prevalence of prediabetes is increasing in the global population and its metabolic derangements may expose to a higher risk to develop type 2 diabetes (T2D) and its cardiovascular burden. Lifestyle modifications might have considerable benefits on ameliorating metabolic status. In light of this scenario, preventive programmes are focusing on the modification of lifestyle that notoriously decreases the incidence of T2D, to reduce the risk and delay T2D and its burden: Diabe...

Weight loss in individuals with Obesity (O) and Type 2 Diabetes (T2D), may improve glycaemic control and weight-related comorbidities, and in some cases, induce diabetes remission. However, body weight control is generally an unmet aim in this population. Thus, there is an increasing need to consider pharmacological approaches to assist weight loss in diabetes-obesity. Glucose-lowering agents as the sodium-glucose co-Transporter 2 inhibitors (SGLT2i) and GLP-1 Receptor Agonist...

Glycemic variability (GV), a complex phenomenon affecting subjects with diabetes, is one of the main contributors to the risk to develop both acute and long-term complications in type 1 (T1D) and type 2 (T2D) subjects. DNA double-strand breaks, apoptosis, overgeneration of reactive oxygen species (ROS) and the induction of some regulatory micro-RNAs, sustain the ominous mechanisms mainly attributable to GV. The characteristic cellular phenotype induced by GV is scarcely define...

Obesity is known to be associated with increased heat production. To maintain normothermia, heat retention in areas of the body with greater adiposity is counteracted by an augmented heat release from the extremities, as the fingernail-beds of hands. A possible cause of the altered thermoregulation in obesity is a dysfunction of the neuro-endocrine system. Repetitive deep Transcranial Magnetic Stimulation (dTMS) was proved to be an effective tool in inducing long lasting chang...

It has been suggested that the selective m-TOR inhibitor, Rapamycin, has been improved the success pancreatic islet allotransplantation (ITx) in type 1 diabetic patients (T1DM). Forty-one ITx were studied. Thirteen T1DM in poor glycemic control underwent a 45-days Rapamycin before ITx followed by standard Edmonton Protocol (EP, group 1, Milan), and they were compared to 28 T1DM patients undergoing EP (group 2, Miami). Outcome measures were daily insulin requirement (DIR), HbA1...

Introduction: Methods to predict clinically meaningful weight loss can help tailor treatment for people with overweight or obesity. LIGHT-UP (NCT03058029), is a multicenter, double-blind, randomized, placebo-controlled study over 25 weeks including 254 people with prediabetes or type 2 diabetes (127 each in the Gelesis200 and placebo arms) with a body mass index between 27 and 40 kg/m2, which demonstrated that Gelesis200 offers a compelling new potential approach in...